Pralsetinib bulk supplier for pharma manufacturers

Pralsetinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100 mg

Reference Brands: Gavreto (USA/EU)

Category: Oncology Cancer Care

Pralsetinib is available in Capsules and strengths such as 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Pralsetinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Pralsetinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

What is Pralsetinib made from? Pralsetinib is made from the active ingredient pralsetinib, a small-molecule tyrosine kinase inhibitor specifically designed to target RET fusion–positive or RET-mutant cancers.

What is Pralsetinib trade name? The trade name of Pralsetinib is Gavreto.

What company makes Pralsetinib? Pralsetinib (Gavreto) is developed and marketed by Blueprint Medicines in collaboration with Genentech (a member of the Roche Group).

What is generic name of Pralsetinib? The generic name is Pralsetinib.

What is brand name of Pralsetinib? The brand name is Gavreto.

Where is Pralsetinib manufactured? Pralsetinib is manufactured in the United States and Switzerland by Blueprint Medicines and Roche facilities following international regulatory standards for oncology drugs.

Yes, Pralsetinib is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Pralsetinib is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Zongertinib

Strength:
60 mg, 90 mg, 120mg

Form: Tablets

Reference Brands: Hernexeos (USA)

View Details
Mirdametinib

Strength:
1 mg, 2mg

Form: Capsules

Reference Brands: Gomekli (USA), Ezmekly (EU/UK)

View Details
Afatinib

Strength:
20 mg, 30mg, 40 mg

Form: Tablets

Reference Brands: Gilotrif (USA), Giotrif (EU/UK)

View Details
Obinutuzumab

Strength:
25 mg/mL

Form: Injection

Reference Brands: Gazyva (USA), Gazyvaro (EU/UK)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.